HealthTree Logo HealthTree Foundation
Donate

Notifications

You're all caught up

HealthTree Logo
Donate
Personal Health Record
  • My Feed
  • Recently viewed

Learn

  • Topics
  • Events

Explore

  • Find treatments & trials
  • Participate in research
  • Find a coach
  • Find a specialist
  • Talk to a patient navigator
  • Get involved
  • For researchers
  • For healthcare providers
  • About us
  • Get involved
  • For researchers
  • For healthcare providers
  • About us

Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Learn more about HealthTree
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Photo of Bonnie Falbo

Bonnie Falbo

12 articles on HealthTree

About Bonnie

Bonnie is a Myeloma Coach and the caregiver for her husband with Multiple Myeloma. They live at the foot of the Blue Ridge Mountains in Afton, VA with their 2 dogs and 2 cats.

Articles by Bonnie

See all 12
  • ASH 2023: How Do We Apply T-Cell Redirection for Myeloma? Part 1: Bispecific Antibody Therapies image
    ASH 2023: How Do We Apply T-Cell Redirection for Myeloma? Part 1: Bispecific Antibody Therapies
    Jan 04, 2024
  • ASH 2023: Dynamic Frailty Status Could Provide Better Prediction of Survival Probability image
    ASH 2023: Dynamic Frailty Status Could Provide Better Prediction of Survival Probability
    Dec 13, 2023
  • ASH 2023: The Next Frontier in CAR T-Cell Therapy- GPRC5D: Auto & Allo in the Spotlight image
    ASH 2023: The Next Frontier in CAR T-Cell Therapy- GPRC5D: Auto & Allo in the Spotlight
    Dec 10, 2023
  • CAR T vs. Bispecific Antibodies: How's a Relapsed/Refractory Myeloma Patient to Choose? image
    CAR T vs. Bispecific Antibodies: How's a Relapsed/Refractory Myeloma Patient to Choose?
    Jul 29, 2021
  • ASCO 2021:  FDA grants Breakthrough Therapy Designation to Teclistamab, a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma image
    ASCO 2021: FDA grants Breakthrough Therapy Designation to Teclistamab, a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma
    Jun 06, 2021
  • ASCO 2020: KRD vs. VRD for Newly Diagnosed Multiple Myeloma image
    ASCO 2020: KRD vs. VRD for Newly Diagnosed Multiple Myeloma
    Jun 01, 2020